| 21/109 | Câncer Loyola EAT, França BHS, Moysés SJ, Moysés ST, Bisinelli JC. Oral cancer, smoking and public health policies in Brazil: a brief review. Applied Cancer Research, São Paulo: Tecmedd, v.31, n.3, p. 102-6, 2011. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.102-6.pdf PROMOCAO DE SAUDE; NEOPLASIAS DE BOCA; CANCER ORAL; SAUDE PUBLICA; FATOR DE RISCO; CIGARRO |
| 22/109 | US=18 / Gastro Tseng JF, Fernandez-del Castilho C, Warshaw AL. Survival after medical and surgical treatment of pancreatic adenocarcinoma. In: Beger HG, Matsuno S, Cameron JL. Diseases of the pancreas: current surgical therapy. New York: Springer, 2008. p. 695-704. ISBN 978-3-540-28655-4. SOBREVIVENCIA APOS O TRATAMENTO; ADENOCARCINOMA DO PANCREAS; ADENOCARCINOMA PANCREATICO; TUMORES RESSECAVEIS |
| 23/109 | US=28 / Urologia Elson PJ. Prognostic factors for survival in metastatic renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 307-22. ISBN 978-1-58829-251-3. |
| 24/109 | US=28 / Urologia Elson PJ. Prognostic factors for survival in metastatic renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 307-22. ISBN 978-1-58829-251-3. |
| 25/109 | US=23-B / Câncer Bowen KA, Riall TS. Periampullary adenocarcinoma: diagnosis and survival after pancreaticoduodenectomy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 211-26. ISBN 978-1-4020-8899-5. CANCER; CANCER GASTROINTESTINAL; CANCER DE PANCREAS; ADENOCARCINOMA PERIAMPOLAR; PANCREATODUODENECTOMIA; FATORES DE RISCO; DIAGNOSTICO; ESTADIAMENTO; TERAPIA ADJUVANTE; TERAPIA NEOADJUVANTE |
| 26/109 | US=39 / Câncer Bonavida B, Jazirehi AR, Vega MI, Huerta-Yepez S, Umezawa K, Suzuki E. Chemo-immunosensitization of resistant B-NHL as a result of rituximab (anti-CD20 mAb)-mediated inhibition of cell survival signaling pathaways. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 29-39. ISBN 978-1-58829-989-5. SENSIBILIZACAO IMUNITARIO; B-NHL; RITUXIMABE; ANTI-CD20 MAB; SINALIZACAO CELULAR |
| 27/109 | US=39 / Câncer McCubrey JA, Franklin RA, Bertrand FE, Taylor JR, Chappell WH, Sokolosky ML, Wong EWT, Abrams SL, Stadelman KM, Misaghian N, Ludwing DL, Basecke J, Libra M, Stivala F, Milella M, Tafuri A, Martelli AM, Lunghi P, Bonati A, Terrian DM, Lehmann BD, Steelman LS. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK and PI3K/Akt pathways to sensitize cancer cells to therapy. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 81-114. ISBN 978-1-58829-989-5. SEGMENTACAO CASCATAS DE SOBREVIVENCIA; ATIVACAO DE RAS / RAF / MEK / ERK; VIAS PI3K/AKT; SENSIBILIZACAO DAS CELULAS CANCEROSAS; APOPTOSE; CANCER HEMATOPOIETICO |
| 28/109 | Câncer Wainstein AJA, Kansaon MJM, Siqueira RR, Conceição SA, Lacerda LT, Oliveira BRR, Santos FAV. Primary anorectal melanoma: report of 4 cases and literature review (case report). Applied Cancer Research, São Paulo: Tecmedd, v.31, n.4, p. 146-50, 2011. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.146-50.pdf |
| 29/109 | Câncer Mota OM, Curado MC, Oliveira JC, Martins E, Cardoso DMM. Staging and survival in esophageal cancer. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.1, p. 6-11, 2012. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2012;32(1)p.6-11.pdf CUIDADOS PALIATIVOS; ESOFAGO. CANCER; ESTADIAMENTO; CIRURGIA |
| 30/109 | US=42 / Gastro Ishikawa O, Ohigashi H, Eguchi H, Sasaki Y, Yamada T, Imaoka S. Survival and late morbidity after resection of pancreatic cancer. In: Beger H, Warshaw A, Büchler M, Kozarek RA, Lerch MM, Neoptolemos JP, Shiratori K, Whitcomb DC, Rau BM. The pancreas: an integrated textbook of basic science, medicine, and surgery. 2nd ed. Massachuetts: Blackwell Scientific Publications, 2008. p. 776-84. ISBN 978-1-4051-4664-7. CANCER DE PANCREAS; RESSECCAO; SOBREVIVENCIA; MORBIDADE TARDIA |
| 31/109 | US=60 / Enfermagem Wright D. Living with cancer long term: the implications of survival. In: Corner J, Bailey C. Cancer nursing: care in context. 2nd ed. St. Louis: Blackwell Science, 2008. p. 638-50. ISBN 978-1-4051-2253-5. |
| 32/109 | US=58 / Câncer Kaina B, Roos WP, Christmann M. DNA damage response and the balance between cell survival and cell death. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 95-108. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. DANOS NO DNA; SOBREVIVENCIA CELULAR; MORTE CELULAR; CHECKPOINTS; CICLO CELULAR; RESPOSTA A DANOS DO DNA; REPARACAO DO ADN; P53; APOPTOSE; RECEPTORES DE MORTE; FAS; CAIXA ELETRONICO; ATR; DROGAS ANTICANCER |
| 33/109 | US=84 / Biol/Mol Xu L. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: ski, snoN, and aKt as negative regulators of smad activity: balancing cell death and cell survival regulatorsnuclear targeting of TGF-B-activated smads in normal and tumor biology. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 139-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 34/109 | US=73 / Biol/Mol Korenberg MJ, Farinha P, Gascoyne RD. Predicting survival in follicular lymphoma using tissue microarrays. In: Korenberg MJ. Microarray data analysis: methods and applications. New Jersey: Humana Press, 2007. p. 255-68. (Methods in molecular biology, v.377) ISBN 978-1-58829-540-8. LINFOMA FOLICULAR; SOBREVIDA; MICROARRAYS DE TECIDOS; BIOMARCADORES |
| 35/109 | US=92 / Biol/Mol Wouters BG, Chiu RK. Apoptosis and alternative modes of cell death: evaluating the importance of apoptosis and other determinants of cell death and survival. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 55-72. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; CLONOGENICA SOBREVIVENCIA; SENESCENCIA; TERAPIA DO CANCER |
| 36/109 | US=2 / Biol/Mol Greten FR, Karin M. Survival pathways: nuclear factor-kB in apoptosis and tumorigenesis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 443-61. ISBN 978-3-527-31237-5. |
| 37/109 | US=2 / Biol/Mol Scheid MP, Woodgett JR. Survival pathways: cell survival through phosphoinositide 3-kinase and protein kinase B. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 463-89. ISBN 978-3-527-31237-5. SOBREVIVENCIA CELULAR; FOSFATIDILINOSITOL 3-QUINASE; PROTEINA QUINASE B; MTOR |
| 38/109 | US=2 / Biol/Mol Drexler HCA, Hekman GM, Albert S, Rapp UR. Survival pathways: survival regulation by ras and raf. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 490-513. ISBN 978-3-527-31237-5. |
| 39/109 | US=2-A / Biol/Mol Clarke PA, Powers M, Workman P. Molecular targets and therapeutics: inhibition of the molecular chaperone heat shock protein 90 in cancer: consequences for the regulation of survival signaling and induction of cell death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 933-65. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBICAO DA CHAPERONE; CHOQUE TERMICO 90; CANCER; REGULACAO DA SINALIZACAO; SOBREVIVENCIA; INDUCAO DE MORTE CELULAR; PROTEINA HSP90 |
| 40/109 | US=32 / Biol/Mol Knudsen S. Survival analysis. In: ___. Cancer diagnostics with DNA microarrays. New Jersey: John Wiley & Sons, 2006. p. 66-8. ISBN 978-0-471-78407-4. CANCER. DIAGNOSTICO; MICROARRAYS DE DNA; ANALISE DA SOBREVIVENCIA; KAPLAN-MEIER; MODELO COX |